New research in Annals of Oncology evaluates “the quality of reporting of the primary end point (PE) and of toxicity in RCTs (randomized, clinical trials) for breast cancer.”  The research indicated, “Of 164 included trials, 33% showed bias in reporting of the PE and 67% in the reporting...

The Cancer Foundation for Personal Appearance celebrates its 2012 Tribute and Salute Dinner! Congratulations to Joseph Minniti, Founder and Director, and to everyone at the foundation who has made a difference in the lives of so many. For more information, please visit The Cancer Foundation for Personal...

A new study in Cell Reports investigates whether chromodomain helicase DNA binding protein 5 (CHD5), a tumor suppressor located in a genomic region frequently deleted in human cancer, involves an interaction with chromatin. Researchers found that “CHD5 binds the unmodified N terminus of H3 through its...